Tourmaline Bio is a clinical-stage biopharmaceutical company developing pacibekitug, an anti-IL-6 mAb, as a treatment option for atherosclerotic cardiovascular disease Pacibekitug is a promising targeted therapy with the potential to reduce systemic inflammation—an independent and significant driver of cardiovascular risk—addressing a
Transaction expands Electric Hydrogen’s co-development and financing solutions for customers Electric Hydrogen, a U.S. manufacturer of advanced electrolyzers, announced it has acquired Ambient Fuels, a leading hydrogen project developer. Rising demand for clean hydrogen in both the U.S. and E.U.
Brought to you by
Copyright © 2026 SalesTechStar. All Rights Reserved. Website Design: SalesTechStar | Privacy Policy
To repurpose or use any of the content or material on this and our sister sites, explicit written permission needs to be sought.
